Philip Morris International Total Cost of Revenue decreased by 9.0% to $3.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.9%, from $3.03B to $3.24B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 7.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.35B | $2.60B | $2.81B | $2.61B | $2.65B | $2.94B | $3.21B | $3.04B | $3.23B | $3.17B | $3.46B | $3.20B | $3.35B | $3.37B | $3.42B | $3.03B | $3.28B | $3.49B | $3.56B | $3.24B |
| QoQ Change | — | +10.3% | +8.1% | -7.1% | +1.5% | +10.8% | +9.4% | -5.4% | +6.3% | -2.0% | +9.4% | -7.7% | +4.7% | +0.6% | +1.7% | -11.5% | +8.2% | +6.3% | +2.1% | -9.0% |
| YoY Change | — | — | — | — | +12.5% | +13.1% | +14.4% | +16.5% | +21.9% | +7.8% | +7.8% | +5.2% | +3.6% | +6.4% | -1.1% | -5.1% | -2.0% | +3.6% | +4.0% | +6.9% |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| SSEA, CIS & MEA | $1.24B | $1.31B | $1.36B | $1.40B | $1.20B | $1.24B | $1.36B | $1.39B |
| Europe | $1.03B | $1.13B | $1.17B | $1.16B | $982.00M | $1.13B | $1.18B | $1.22B |
| Americas | $354.00M | $380.00M | $372.00M | $425.00M | $370.00M | $420.00M | $418.00M | $506.00M |
| EA, AU & PMI GTR | $577.00M | $528.00M | $468.00M | — | $488.00M | $489.00M | $535.00M | $449.00M |
| EA, AU & PMI DF | $502.75M | $502.75M | $502.75M | $502.75M | — | — | — | — |
| Wellness and Healthcare | $67.00M | $67.00M | $67.00M | $67.00M | — | — | — | — |
| Total | $3.20B | $3.35B | $3.37B | $3.42B | $3.03B | $3.28B | $3.49B | $3.56B |
EA, AU & PMI DF, Wellness and Healthcare are derived from annual filings.
Americas, EA, AU & PMI DF, EA, AU & PMI GTR, Europe, SSEA, CIS & MEA, Wellness and Healthcare were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '26 |
|---|---|
| International Combustibles | $1.85B |
| International Smoke-Free | $1.15B |
| Total | $3.24B |